ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 196 filers reported holding ANIKA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 15.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +7.7% | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $13,000 | -13.3% | 580 | 0.0% | 0.00% | – |
| Q1 2022 | $15,000 | -28.6% | 580 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -16.0% | 580 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | 0.0% | 580 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -10.7% | 580 | -14.5% | 0.00% | – |
| Q1 2021 | $28,000 | -37.8% | 678 | -32.2% | 0.00% | – |
| Q4 2020 | $45,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | -7.9% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | +31.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | -64.9% | 1,000 | -63.0% | 0.00% | – |
| Q3 2019 | $148,000 | -81.6% | 2,700 | -86.4% | 0.00% | – |
| Q2 2019 | $804,000 | +3920.0% | 19,800 | +3200.0% | 0.00% | – |
| Q4 2018 | $20,000 | -33.3% | 600 | -14.3% | 0.00% | – |
| Q3 2018 | $30,000 | -6.2% | 700 | -30.0% | 0.00% | – |
| Q2 2018 | $32,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |